ThredUp Inc. (TDUP)’s 80% Gross Margin Shines, But Can Promotions Delay Profitability?
On August 5, ThredUp Inc.
AI Data Centers Are Running Out of Water. This $6 Stock Has a Fix
Major AI stocks are getting expensive and everyday investors are in search of low-priced names that have the potential to return huge profits in the long term.
Hedge Funds
News & Analysis
Top Fund Managers
Best Performing Funds
Featured Content
Insider Trading
News & Analysis
Latest Insider Purchases
Walsh bought 500,000 Attovia Therapeutics Inc. shares at $17.00
Walsh bought 85,000 Attovia Therapeutics Inc. shares at $21.00
Goldman bought 500,000 Attovia Therapeutics Inc. shares at $17.00
Goldman bought 85,000 Attovia Therapeutics Inc. shares at $21.00
Schwartz bought 60,000 Oppfi Inc. shares at $7.13
Latest Insider Sales
Walsh sold 76,418 Attovia Therapeutics Inc. shares at $21.04
Walsh sold 6,763 Attovia Therapeutics Inc. shares at $21.61
Walsh sold 100 Attovia Therapeutics Inc. shares at $21.99
Walsh sold 1,163 Attovia Therapeutics Inc. shares at $22.19
Walsh sold 700 Attovia Therapeutics Inc. shares at $22.07
Featured Content
Do not Miss
Could Dutch Bros (BROS)’ Salad and Go Deal Fuel Its Next Wave of Growth?
Dutch Bros Inc. (NYSE:BROS) announced on August 5 an agreement to acquire the real estate and site assets of up to 65 Salad and Go drive-thru locations across Arizona, Nevada, Oklahoma, and Texas.
Could Danaher Corporation (DHR)’s Bioprocessing Recovery Give Bio-Rad Laboratories (BIO) Stock a Boost?
When biopharmaceutical suppliers report earnings, ripples move fast across the sector. On July 21, Danaher Corporation (NYSE:DHR) reported its Q2 2026 results.
Incyte Corporation (INCY) has the Bigger Revenue Base, but Could Halozyme Therapeutics, Inc. (HALO) have the Better Economics?
On July 20, Halozyme Therapeutics, Inc.
Could Arcus Biosciences (RCUS) and Summit Therapeutics (SMMT)’s Cancer Drug Partnership Create a New Treatment Standard?
On July 22, Arcus Biosciences, Inc. (NYSE:RCUS) and Summit Therapeutics Inc.
Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab?
On July 23, Genmab A/S (NASDAQ:GMAB) and AbbVie Inc. (NYSE:ABBV) clarified a key clinical setback regarding their jointly developed T-cell engaging bispecific antibody, epcoritamab (DuoBody-CD3xCD20).
Doximity Doubled, Then Gave Most of It Back. Here’s Why the Market Doesn’t Trust the Rally
For a few hours on August 7, Doximity, Inc. (NYSE:DOCS) appeared to be the story of the earnings season.
e.l.f Beauty, Inc. (ELF) Crushes Q1 2027 Estimates as Rhode Fuels a Major Growth Acceleration
Pre-earnings options volume in e.l.f Beauty, Inc. (NYSE:ELF) traded at 1.2x normal levels on August 5, with calls leading puts 8:7.
Johnson & Johnson (JNJ)’s $5.5B Talc Settlement: Turning Point or Temporary Relief?
The World Health Organization projects that the share of the world's population aged 60 years and older will almost double from 12% in 2015 to 22% by 2050.
Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine?
According to reports, on August 6, Harrow, Inc. (NASDAQ:HROW) announced a definitive agreement to acquire global rights to Tyrvaya nasal spray from Viatris Inc. (NASDAQ:VTRS) for up to $100 million.
Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery?
Two ophthalmic technology leaders, Alcon Inc. (NYSE:ALC) and RxSight, Inc.
Royalty Pharma plc (RPRX) vs. AstraZeneca PLC (AZN): Which Biopharma Model Offers the Better Growth Story?
In the life sciences sector, capital allocation often tells a clearer story than pure drug discovery.
Could HCA Healthcare, Inc. (HCA) Stock Rebound After Guidance Cuts and Payer Pressure?
HCA Healthcare, Inc. (NYSE:HCA) reported its second-quarter 2026 financial results on July 24, confirming the figures previewed earlier in the month.
Could GSK plc (GSK)’s Pipeline Acceleration Unlock a New Growth Era?
On July 28, GSK plc (NYSE:GSK) reported its second-quarter financial results, delivering strong core operational performance and showcasing steady commercial momentum.
Could Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD)’s Partnership Create the Next Big Pharma Growth Engine
Two biopharma giants, Merck & Co., Inc. (NYSE:MRK) and Gilead Sciences, Inc.
From Courtroom Rivals to Corporate Partners: Archer Buys Its Way Into Boeing's Orbit
Five years ago, Wisk Aero sued Archer Aviation Inc. (NYSE:ACHR) for allegedly stealing its trade secrets.
Could AbbVie Inc. (ABBV)'s Post-Humira Transformation Drive the Next Phase of Growth?
AbbVie Inc. (NYSE:ABBV) reported its first-quarter 2026 financial results, delivering worldwide net revenues of $15.002 billion, an increase of 12.4% on a reported basis (10.3% operationally).
SpaceX's Most Loyal Buyers Blinked
Retail investors were steadfast for nearly eight weeks after Space Exploration Technologies Corp (NASDAQ:SPCX) went public.
Atmos Energy (ATO) Posts Solid Growth and Reaffirms Guidance
Atmos Energy (NYSE:ATO) posted year-to-date fiscal 2026 net income of $1.2 billion, or $7.33 per diluted share, a 14.5% increase over the prior-year period, according to the company's Q3 2026 earnings...
From Chinese AI to Global ETFs: STARTRADER Launches 45 New 24/7 Stock and ETF CFDs
Where previous 24/7 expansions were anchored around specific themes, this one is defined by its breadth.
Radian's (RDN) Revenue Jumped 93%, So Why Are Shares So Cheap?
Radian Group (NYSE:RDN) delivered its Q2 2026 earnings on August 5, and the numbers marked a turning point.
Marex (MRX) Popped 19% In A Day. Can It Keep Climbing?
On August 12, Marex Group (NASDAQ:MRX) turned in a quarter so far ahead of expectations that its stock jumped nearly 19% in a single session.
Retail Investors Think This Under-$10 Drone Stock Can Double
Retail investors are looking beyond Nvidia to find long-term investments that will pay off. To find the small names investors believe have potential, we scoured Reddit communities like r/investing and...
Is UGI's (UGI) Utility Win Enough To Offset Propane Pain?
UGI (NYSE:UGI) walked into its fiscal 2026 third-quarter earnings call on August 6 with a split story to tell.
Qiagen (QGEN) Beat Its Own Guidance, So Why Did Margins Slip?
Qiagen (NYSE:QGEN) walked into its second quarter of 2026 bracing investors for a roughly 2% sales decline.
Strong Beats Mask Zillow’s (Z) Restructuring And Headwinds
Zillow Group (NASDAQ:Z) delivered a second quarter that beat its own outlook on nearly every line, then turned around and eliminated jobs and reshuffled its leadership team.
Allient (ALNT) Just Posted Record Orders. Is The Growth Sustainable?
On August 6, Allient (NASDAQ:ALNT) reported its second-quarter fiscal 2026 results, where revenue climbed 10% year-over-year to $153.8 million, gross margin hit a record 34.9%, and orders jumped 49% to...
Privia Health's (PRVA) Guidance Keeps Rising, So Is The Stock Keeping Pace?
Privia Health (NASDAQ:PRVA) just turned in a quarter that checked every box management set for itself, and then raised the bar again for the rest of the year.
Prestige Consumer Healthcare (PBH) Bets Big On M&A, But Can Clear Eyes Recover?
Prestige Consumer Healthcare (NYSE:PBH) closed two acquisitions within three weeks this summer, adding roughly $240 million in annualized revenue to a portfolio anchored by Dramamine and Compound W.
Microsoft (MSFT) Is Pulling Back From China. Should Investors Worry?
Microsoft (NASDAQ:MSFT) once treated the idea of leaving China as unthinkable.
WeRide (WRD) Wants The World, But Can It Turn A Profit?
On August 13, Reuters reported that WeRide (NASDAQ:WRD) is scouting Australia, South Korea, Japan, and Southeast Asia for its next robotaxi markets, one day after posting a quarter that more than doubled...
IREN’s $100 Bull Case Hinges on a 5-10x AI Cloud Advantage
Iren Ltd. (NASDAQ:IREN) has been transitioning itself from being a Bitcoin miner into a major neocloud provider.
Hedge Fund Investor Letters Q2 2026
In this article, we will share the hedge fund investor letters for the second quarter of 2026.
Microchip Technology (MCHP) Signals Cyclical Recovery with Q4 Beat and Strong Guidance
Sycamore Capital Management, a franchise of Victory Capital Management, released its Q2 2026 investor letter for "Sycamore Mid Cap Value Equity Strategy". A copy of the letter can be downloaded here.
Loss of Market Share in U.S. Antitrust Consulting Pressures FTI Consulting’s (FCN) Top-Line Performance
Sycamore Capital Management, a franchise of Victory Capital Management, released its Q2 2026 investor letter for "Sycamore Mid Cap Value Equity Strategy". A copy of the letter can be downloaded here.
Hedge Fund Resource Center Lists
11 Largest Uranium Producing Countries in the World
5 Largest Uranium Producing Countries in the World
12 Cheapest Cigarette Brands in 2026
5 Cheapest Cigarette Brands in 2026
12 Best Cheap Colognes for Men That Smell Amazing
12 Fastest Declining Economies in the World in 2026
5 Fastest Declining Economies in the World in 2026
10 Most Popular Stocks on Robinhood in 2026
25 Countries with the Highest Debt to GDP Ratios
15 States with the Most Gun Violence in the US
9 Undervalued Chemical Stocks to Buy According to Hedge Funds
7 Most Promising Psychedelic Stocks According to Hedge Funds
7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds
15 Innovative Healthcare Stocks to Buy According to Analysts
9 High Growth Small Cap Stocks That Are Profitable
20 Most Profitable Stocks of the Last 20 Years
15 High Growth Mid-Cap Stocks to Buy
Top 10 Oncology Stocks to Buy Now
10 Best Investments During A Recession
7 Best Rare Earth Stocks to Buy According to Hedge Funds
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending
New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)
J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum
11 Best Cancer Stocks to Buy Right Now
40 Most Unfriendly Countries in the World
30 Unhappiest Countries in the World in 2025
Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut
5 Countries with the Most Beautiful Women in the World
20 Countries with the Most Beautiful Women in the World
20 US Cities with the Highest Homeless Population Per Capita
20 Countries with the Highest Homeless Population
12 Countries with the Highest Bond Yields in the World
20 Countries with the Most Battle Tanks in the World
12 Best Nasdaq Stocks Under $20 to Buy Now
10 Best Low Beta Tech Stocks to Buy According to Analysts
10 Worst Performing Currencies of 2024
15 States with the Best Weed in America
16 Countries with the Largest Proven Oil Reserves in the World
16 Highest Quality Chocolate Brands in the US
20 Countries with the Strongest Armies in the World
Top 13 English Speaking Countries in Asia
20 States with Highest Female to Male Ratio in the US
40 Best Places to Visit in Europe Before You Die
20 States with the Lowest Life Expectancy in the US
25 Cities with the Highest Homeless Population in the World
20 Countries With The Best English Accent in The World
30 Cities with the Highest Weed Consumption in the US
25 Countries with the Highest Alcohol Consumption per Capita
10 Best Gold Stocks Under $30
10 Best Genomics Stocks To Buy Right Now
